文献速递脊柱外科

人脂肪来源干细胞分化的组织工程骨抑制无胸腺大鼠模型中的后外侧融合

Tissue Engineered Bone Differentiated From Human Adipose Derived Stem Cells Inhibit Posterolateral Fusion in an Athymic Rat Model.
PubMed 文献 · Spine (Phila Pa 1976) · 2018-01-01

在31只无胸腺大鼠L4-L5后外侧融合模型中,比较接种肥大软骨细胞支架与单纯支架的融合效果。3周时组织工程骨组无部分或完全融合,脱细胞支架组62.5%完全融合、12.5%部分融合(P=0.013);6周时组织工程骨组无融合、50%部分融合,脱细胞支架组87.5%融合(P=0.002)。作者结论为组织工程骨抑制后外侧融合,不是有前景的性价比高的骨移植替代物。

要点

  • 3周时组织工程骨组无部分或完全融合,脱细胞支架组62.5%融合、12.5%部分融合(P=0.013)。
  • 6周时组织工程骨组无融合、50%部分融合,脱细胞支架组87.5%融合(P=0.002)。
  • 作者结论为组织工程骨抑制无胸腺大鼠后外侧融合,不代表有前景的性价比高的骨移植替代物。

核心结论

  • 由肥大软骨细胞构成的组织工程骨在无胸腺大鼠模型中抑制后外侧融合,因此不代表有前景的性价比高的骨移植替代物。

研究设计与样本

  • 无胸腺大鼠脊柱关节融合生物学增强试验,在31只无胸腺大鼠L4-L5行单节段横突间融合。
  • 15只大鼠植入接种肥大软骨细胞的支架,16只植入单纯支架;一半大鼠在3周处死,另一半在6周处死。
  • 牛骨核心经灭菌和脱细胞处理制备支架,人脂肪来源间充质干细胞(ADSC)经三向分化检测验证后接种于干燥支架,在模拟软骨内骨化并产生肥大软骨细胞的培养基中培养5周。
  • 融合通过二维和三维微型计算机断层扫描(μCT)分析及组织学评估。

主要发现

  • 3周时组织工程骨组无部分或完全融合,脱细胞支架组62.5%融合、另12.5%部分融合(P=0.013)。
  • 6周时组织工程骨组无融合、50%部分融合,脱细胞支架组87.5%融合(P=0.002)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Biological augmentation spinal arthrodesis trial in athymic rats. OBJECTIVE: To assess the efficacy of tissue-engineered bone to promote L4-L5 intertransverse process fusion in an athymic rat model. SUMMARY OF BACKGROUND DATA: Each year in the United States, over 400,000 spinal fusion surgeries are performed requiring bone graft. The current gold standard for posterolateral lumbar fusion is autogenous iliac crest bone graft (ICBG), but the harvesting of ICBG is associated with increased operative time and significant complications. This being the case, an alternative cost-effective bone graft source is needed. METHODS: Bovine bone cores were sterilized and decellularized for scaffold production. Human adipose derived mesenchymal stem cells (ADSC) were obtained and verified by tridifferentiation testing and seeded onto dried scaffolds. The seeded cores were cultured for 5 weeks in culture medium designed to mimic endochondral ossification and produce hypertrophic chondrocytes. Single-level intertransverse process fusions were performed at the L4-L5 level of 31 athymic rats. Fifteen rats were implanted with the hypertrophic chondrocyte seeded scaffold and 16 had scaffold alone. Half of the study rats were sacrificed at 3 weeks and the other half at 6 weeks. Spinal fusion was assessed using 2D and 3D micro computed tomography (μCT) analysis and tissue histology. RESULTS: At 3 weeks, none of the tissue engineered rats had partial or complete fusion, whereas 62.5% of the decellularized rats fused and another 12.5% had partial fusions (P = 0.013). At 6 weeks, none of the tissue engineered rats fused and 50% had partial fusions, whereas 87.5% of the decellularized rats fused (P = 0.002). CONCLUSION: Tissue engineered bone composed of hypertrophic chondrocytes inhibits posterolateral fusion in an athymic rat model and therefore does not represent a promising cost-effective bone graft substitute. LEVEL OF EVIDENCE: N/A.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Saifi C, Bernhard J, Shillingford JN, et al. Tissue Engineered Bone Differentiated From Human Adipose Derived Stem Cells Inhibit Posterolateral Fusion in an Athymic Rat Model. Spine (Phila Pa 1976). 2018. PMID: 28816826. doi:10.1097/BRS.0000000000002384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。